Back to search
Immune Tolerance
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Immune Tolerance trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Immune Tolerance trials you may qualify forThe proposed study uses a novel and rigorous randomized cross-over study design in youth (18-23y) with late and non-late chronotype (n=35 per group) to assess t…
This interventional study aims to validate an early heated protein introduction protocol in cow's milk allergic children who already developed tolerance towards…
This study will evaluate the recommended dose for further clinical development, safety, tolerability, anti-tumor activity, immunogenicity, pharmacokinetics and…
The purpose of this study is to find out if an investigational treatment will allow kidney transplant recipients to better accept their new kidney and stop immu…
During intermittent hemodialysis (IHD), the occurrence of intradialytic hemodynamic instability (IHI) is frequent in ICU and impacted morbidity and mortality. B…
Patients with pancreatic cancer (pancreatic ductal adenocarcinoma (PDAC) and pancreatic neuroendocrine tumor (NET)) commonly experience fat malabsorption due to…
This Phase I \& II study evaluates the safety and tolerability of 8 weeks of daily supplementation with high-dose versus standard-dose of a novel three-strain p…
The purpose of this clinical trial is to find out whether one type of fish oil works better than another at improving metabolic health in people who are at high…
Vitiligo is an autoimmune depigmentation disorder affecting 0.5 to 1% of the population worldwide. Vitiligo lesions are characterized by a progressive loss of p…